| Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study M García-Grimshaw, LE Hernández-Vanegas, I Núñez, ... Clinical Immunology 229, 108786, 2021 | 102 | 2021 |
| Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study I Núñez, M García-Grimshaw, SE Ceballos-Liceaga, C Toledo-Salinas, ... The Lancet Regional Health–Americas 17, 2023 | 43 | 2023 |
| Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients I Núñez, ÁA Priego-Ranero, HB García-González, B Jiménez-Franco, ... Clinical Immunology 225, 108682, 2021 | 25 | 2021 |
| Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines M García‐Grimshaw, JA Galnares‐Olalde, OY Bello‐Chavolla, ... European journal of neurology 29 (11), 3368-3379, 2022 | 23 | 2022 |
| A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce … S Fragoso-Saavedra, DA Iruegas-Nunez, A Quintero-Villegas, ... BMC infectious diseases 20, 1-7, 2020 | 18 | 2020 |
| Fulminant mpox as an AIDS-defining condition: useful or stigmatising? I Núñez, SI Valdés-Ferrer The Lancet 401 (10380), 881-884, 2023 | 14 | 2023 |
| Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial S Fragoso-Saavedra, I Núñez, BM Audelo-Cruz, S Arias-Martínez, ... Molecular Medicine 28 (1), 131, 2022 | 14* | 2022 |
| Impact of healthcare strain on access to mechanical ventilation and mortality of hospitalized COVID-19 patients: a retrospective cohort study I Núñez, A Soto-Mota Transactions of The Royal Society of Tropical Medicine and Hygiene 117 (5 …, 2023 | 13* | 2023 |
| Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capital I Núñez, Y Caro-Vega, PF Belaunzarán-Zamudio Public health 205, 187-191, 2022 | 12 | 2022 |
| Result turnaround time of RT-PCR for SARS-cov-2 is the main cause of COVID-19 diagnostic delay: A country-wide observational study of mexico and colombia I Núñez, PF Belaunzarán-Zamudio, Y Caro-Vega Revista de investigación clínica 74 (2), 71-80, 2022 | 12 | 2022 |
| Impact of RT-PCR test false-negative results for SARS-CoV-2 surveillance in Mexico I Núñez, PF Belaunzarán-Zamudio, Y Caro-Vega Revista de investigación clínica 73 (2), 120-126, 2021 | 9 | 2021 |
| Seizures following COVID‐19 vaccination in Mexico: a nationwide observational study I Núñez, M García‐Grimshaw, CY Castillo Valencia, DE Aguilera Callejas, ... Epilepsia 63 (10), e144-e149, 2022 | 7 | 2022 |
| Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study I Núñez, J Gillard, S Fragoso-Saavedra, D Feyaerts, L Islas-Weinstein, ... Frontiers in Medicine 10, 2023 | 6* | 2023 |
| Harm of early dexamethasone for COVID-19 and bias in randomized trials I Núñez, Y Caro-Vega, A Soto-Mota European journal of internal medicine 107, 100-101, 2023 | 5 | 2023 |
| Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors I Núñez, B Crabtree-Ramirez, BE Shepherd, TR Sterling, P Cahn, ... International Journal of Infectious Diseases 122, 469-475, 2022 | 5 | 2022 |
| Assessing the evidence on remdesivir I Núñez, A Soto-Mota The Lancet Infectious Diseases 21 (12), 1630, 2021 | 5* | 2021 |
| Psychological and psychiatric events following immunization with five different vaccines against SARS-CoV-2 M García-Alanis, M Morales-Cárdenas, LN Toapanta-Yanchapaxi, ... Vaccines 10 (8), 1297, 2022 | 4 | 2022 |
| Predictors of laboratory-confirmed mpox in people with mpox-like illness I Núñez, SE Ceballos-Liceaga, A de la Torre, G García-Rodríguez, ... Clinical Microbiology and Infection 29 (12), 1567-1572, 2023 | 3 | 2023 |
| Hospitalization as an outcome in ambulatory COVID-19 trials—not applicable in every setting I Núñez, SI Valdés-Ferrer, A Soto-Mota Clinical Microbiology and Infection 28 (9), 1187-1188, 2022 | 3 | 2022 |
| Heterogeneity of hypoxemia severity according to pulse oximetry and blood gas analysis in COVID-19 pneumonia I Núñez, A Soto-Mota Medicina intensiva, 2021 | 3 | 2021 |
Sergio I. Valdés-Ferrer, MD, PhDDepartments of Neurology and Infectious Diseases, Instituto Nacional de Ciencias Médicas y NutriciónDirección de correo verificada de incmnsz.mx
